In this paper, we established the clinical significance of ESE-1 expression in specific breast cancer subtypes and elucidated a mechanistic role for ESE-1 in these subtypes using a preclinical cell culture model and in vivo xenograft tumor formation. This evidence concerns the gene ELF3 and neoplasm.